Citi Resumes SXC Health Solutions Coverage: PT to $120, Reiterates Buy


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Citi resumed its coverage of SXC Health Solutions (NASDAQ: SXCI) on Friday after the company completed its merger with Catalyst Health Solutions effective July 2. Citi raised its SXC Health Solutions price target from $84 to $120 and reiterated its Buy rating.In the report, Citi stated, "We continue to believe SXCI's unique business model that includes Healthcare IT, combined with CHSI's centers of excellence, will resonate with mid-size and increasingly Fortune 500 clients."Shares of SXC Health Solutions were trading at $96.43 at the time of posting, up 0.06% from Thursday's market close.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorPrice TargetInitiationReiterationIntraday UpdateAnalyst RatingsCiti